Objective
VTDR, T2DM, vision-threatening diabetic retinopathy
DIABETES MELLITUS TYPE 2
Edited by: Chunjie Jiang, University of Pennsylvania, United StatesReviewed by: Mengmeng Zhai, Alliance Pharma, United States; Zhiying Xie, University of Washington, United States†Present address: Di Gong, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China‡These authors have contributed equally to this work and share first authorshipThis study aims to develop and evaluate a non-imaging clinical data-based nomogram for predicting the risk of vision-threatening diabetic retinopathy (VTDR) in diabetes mellitus type 2 (T2DM) patients.